Tag: fetal bovine serum market trends

  • Key Insights into the Fetal Bovine Serum Market’s Growth Opportunities for 2024-2033

    Key Insights into the Fetal Bovine Serum Market’s Growth Opportunities for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Estimated Growth Rate for the Fetal Bovine Serum Market Between 2024 and 2033?

    In recent times, the size of the fetal bovine serum market has significantly expanded. It is projected to increase from $1095.25 billion in 2023 to $1176.47 billion in 2024, indicating a compound annual growth rate (CAGR) of 7.4%. Factors like the expansion of the biopharmaceutical industry, an increase in cell-based therapies, and the need for quality and consistency are responsible for the growth seen in the historic period.

    The market for fetal bovine serum is predicted to undergo significant expansion within the next few years. Its worth is anticipated to reach $1644.06 billion in 2028, developing at a compound annual growth rate (CAGR) of 8.7%. This expansion during the projection period can be ascribed to the rise in the use of cell therapies, the development of advanced treatments, the concentration on substitutes that do not involve animals, and strategic associations between suppliers and consumers. The prediction period will be characterized by a focus on product quality and traceability, worldwide collaboration and partnerships, strategic mergers and acquisitions, customized fetal bovine serum products, regulatory compliance and ethical procurement.

    Claim Your Free Sample of the Global Fetal Bovine Serum Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

    What Are the Primary Contributors to the Growth of the fetal bovine serum Market?

    The surge in the necessity for biopharmaceuticals is forecasted to fuel the growth of the fetal bovine serum market during the predicted period. Biopharmaceuticals, which are medicinal products extracted from biological entities such as animals, humans, and microorganisms, are produced using biotechnology. The most commonly utilized alternative for animal cell culture media is the fetal bovine serum (FBS). It is extensively relied upon by pharmaceutical corporations, diagnostic labs, and researchers for a significant portion of their cell culture demands in biologics analysis. ProClinical Limited, a lifesciences service and consulting company from the UK, recorded sales of US$36.15mn in 2022 for its pharmaceuticals and vaccines branches, up 11% YOY. As a result, the burgeoning demand for biopharmaceuticals is boosting the expansion of the fetal bovine serum market.

    Which Key Segments Comprise the Fetal Bovine Serum Market?

    1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products

    2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications

    3) By End-User: Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users

    What Are the Key Trends Reshaping the Fetal Bovine Serum Market?

    A prominent trend observed in the fetal bovine serum market is the rise in partnerships between corporate entities and research institutions. These collaborations are aimed at boosting production capacities, broadening market penetration and innovating new products. As a case in point, GE Healthcare from the US entered into a collaboration with New Zealand’s Oritain to create an independent verification method to establish the country of provenance for fetal bovine serum (FBS). The identification of origin is vital for bio-manufacturing firms since FBS from different countries carry different levels of risk for viral contamination.

    Order Now for Fast Delivery of Your Fetal Bovine Serum Market Report!

    https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

    What Are the Top Regions Fueling Growth in the Fetal Bovine Serum Market?

    North America was the largest region in the fetal bovine serum market in 2023. Asia-Pacific recorded the fastest growth during the forecast period. The regions covered in the fetal bovine serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Fetal Bovine Serum Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the fetal bovine serum market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Fetal Bovine Serum Market Include

    1. Fetal Bovine Serum Market Executive Summary

    2. Fetal Bovine Serum Market Segments

    3. Fetal Bovine Serum Market Size And Template Market Growth Rate

    4. Key Fetal Bovine Serum Market Trends

    5. Major Fetal Bovine Serum Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Fetal Bovine Serum Market

    26. Top Fetal Bovine Serum Companies

    27. Fetal Bovine Serum Market Opportunities And Strategies

    28. Fetal Bovine Serum Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Fetal And Neonatal Monitoring Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/fetal-and-neonatal-monitoring-devices-global-market-report

    3D Cell Culture Technologies Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

    Healthcare E-Commerce Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Fetal Bovine Serum Market Report 2024

    Top 5 Insights From The Fetal Bovine Serum Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Fetal Bovine Serum Global Market Report 2024, the fetal bovine serum market is expected to show promising growth in the forecast period.

    The fetal bovine serum (FBS) market has experienced substantial growth in recent years and is projected to continue expanding robustly. This blog delves into the market’s recent growth, future projections, and key trends that are shaping the industry’s trajectory.

    Recent Market Growth

    Market Size and Growth Rate

    • 2023 Market Size: $1,095.25 billion
    • 2024 Market Size: $1,176.47 billion
    • CAGR (2023-2024): 7.4%

    Historical Growth Drivers

    • Biopharmaceutical Industry Expansion: Increased demand for FBS in drug development and production.
    • Rise in Cell-Based Therapies: Growing use of cell therapies requiring high-quality FBS.
    • Quality and Consistency Requirements: Demand for reliable and consistent FBS for research and clinical applications.

    Future Market Projections

    Projected Growth

    • 2028 Market Size: $1,644.06 billion
    • CAGR (2024-2028): 8.7%

    Future Growth Drivers

    • Adoption of Cell Therapies: Increased utilization of cell-based therapies in treating various diseases.
    • Advanced Therapeutics Emergence: Development of new therapeutic modalities requiring FBS.
    • Focus on Animal-Free Alternatives: Exploration of alternatives to traditional FBS.
    • Strategic Supplier-Customer Relationships: Strengthened collaborations to ensure steady supply and innovation.

    View More On The Fetal Bovine Serum Market Report 2024 – https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

    Major Trends Shaping the Market

    Focus on Quality and Traceability

    • Ensuring high standards of quality and traceability in FBS production.

    Global Collaboration and Partnerships

    • Increased partnerships and collaborations across global markets to enhance supply chains and research capabilities.

    Strategic Mergers and Acquisitions

    • Ongoing mergers and acquisitions driving market consolidation and innovation.

    Customized Fetal Bovine Serum Products

    • Development of tailored FBS products to meet specific research and clinical needs.

    Regulatory Compliance and Ethical Sourcing

    • Adherence to stringent regulatory standards and ethical sourcing practices.

    Surging Demand in the Biopharmaceutical Sector

    Driving Market Growth

    • Increased Biopharmaceutical Demand: Rising demand for biopharmaceuticals, driven by advancements in biologics research.
    • Reliance on FBS: FBS is a critical component in cell culture media for biopharmaceutical production.

    Case in Point

    • ProClinical Limited (2022): Sales for pharmaceuticals and vaccines segments reached $36.15 million, an 11% YOY increase, reflecting the growing biopharmaceutical market’s impact on FBS demand.

    Leading Companies and Innovations

    Key Market Players

    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • Corning Incorporated
    • Cytiva
    • VWR International
    • Sartorius AG
    • GenClone Inc.
    • Gemini Bio-Products
    • Access Biologicals LLC
    • Nucleus Biologics
    • ZenBio Inc.
    • Biowest
    • Axil Scientific Pte Ltd.

    Focus on USDA-Approved Products

    • Thermo Fisher Scientific’s Gibco Fetal Bovine Serum: A USDA-approved, heat-inactivated product suitable for various research applications, reflecting the industry’s commitment to quality and safety.

    Market Segmentation

    By Product

    • Charcoal Stripped
    • Chromatographic
    • Dialyzed Fetal Bovine Serum
    • Exosome Depleted
    • Stem Cell
    • Other Products

    By Application

    • Drug Discovery
    • Cell Culture Media
    • In Vitro Fertilization
    • Human and Animal Vaccine Production
    • Diagnostics
    • Other Applications

    By End-User

    • Research and Academic Institutes
    • Biotechnology and Pharmaceutical Industry
    • Other End-Users

    Regional Insights

    Largest Market

    • North America: Leading the FBS market in 2023.

    Fastest Growing Region

    • Asia-Pacific: Expected to record the fastest growth during the forecast period.

    Conclusion

    The fetal bovine serum market is on a significant growth trajectory, driven by the expanding biopharmaceutical industry, rising cell-based therapies, and increasing demand for quality and consistency in research and clinical applications. As the market continues to evolve, strategic partnerships, innovation in product offerings, and adherence to regulatory standards will be crucial in shaping its future.

    Request A Sample Of The Global Fetal Bovine Serum Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=4109&type=smp